2011
DOI: 10.1186/1471-2369-12-26
|View full text |Cite
|
Sign up to set email alerts
|

Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome

Abstract: BackgroundPulmonary-renal syndrome associated with anti-glomerular basement membrane (GBM) antibodies, also known as Goodpasture's syndrome, is a rare but acute and life-threatening condition. One third of patients presenting as anti-GBM antibody positive pulmonary-renal syndrome or rapidly progressive glomerulonephritis are also tested positive for anti-neutrophil cytoplasmic antibodies (ANCA). Whilst anti-GBM disease is considered a non-relapsing condition, the long-term course of double-positive patients is… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…Dual positive patients have higher relapse rate then those with anti-GBM antibodies alone [6,9]. This suggests that an early indicator of disease relapse is needed in monitoring disease activity in double-positive patients, such as anti-hLAMP2 antibody [36,37]. …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Dual positive patients have higher relapse rate then those with anti-GBM antibodies alone [6,9]. This suggests that an early indicator of disease relapse is needed in monitoring disease activity in double-positive patients, such as anti-hLAMP2 antibody [36,37]. …”
Section: Discussionmentioning
confidence: 99%
“…The recurrence of disease activity with elevation of MPO-ANCA can occur many months after clinical remission, affecting either both lungs and kidneys or only one of these organs [6,12,13,31,32,41]. Most relapses responded well to methylprednisolone and/or cyclophosphamide therapy [12,36]. …”
Section: Discussionmentioning
confidence: 99%
“…There are at least two reported cases which have dual positivity for anti-GBM antibody and ANCA with MN [14,15]. One case [14] had both perinuclear and cytoplasmic ANCAs, and the other [15] had antibodies to both human lysosomal membrane protein 2 (anti-hLAMP-2) and MPO-ANCA.…”
Section: Discussionmentioning
confidence: 99%
“…One case [14] had both perinuclear and cytoplasmic ANCAs, and the other [15] had antibodies to both human lysosomal membrane protein 2 (anti-hLAMP-2) and MPO-ANCA. The significance of the dual positivity of perinuclear and cytoplasmic ANCA or MPO-ANCA and anti-hLAMP-2 antibody is unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-EEA1 antibodies are seen in patients with neurological diseases and quantitated using an addressable laser bead immunoassay on Luminex platform [ 15 ]; anti-LAMP2 antibodies have been also recently studied in ANCA associated vasculitis [ 16 ]. Overall, the increasing interest for these “minor” autoantibodies may lead to the development of easier and more practicable methods for their detection.…”
Section: Discussionmentioning
confidence: 99%